Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Devriese

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Plos One|April 10, 2018
First- and second-line bevacizumab in ovarian cancer: A Belgian cost-utility analysisMattias Neyt, Joan Vlayen, Stephan Devriese, et al.
Health Policy (Amsterdam, Netherlands)|July 10, 2018
A multi-criteria decision approach for ranking unmet needs in healthcareIrina Cleemput, Stephan Devriese, Laurence Kohn, et al.
Pharmacoeconomics - Open|August 4, 2022
An EQ-5D-5L Value Set for BelgiumNicolas Bouckaert, Irina Cleemput, Stephan Devriese, et al.
Pharmacoeconomics|January 11, 2025
Projections of Public Spending on Pharmaceuticals: A Review of MethodsIrina Odnoletkova, Patrice X Chalon, Stephan Devriese, et al.
Journal of Thrombosis and Thrombolysis|March 23, 2012
Economic evaluation of the use of point-of-care devices in patients with long term oral anticoagulationSophie Gerkens, Jeannine Gailly, Caroline Obyn, et al.
Health Policy (Amsterdam, Netherlands)|January 13, 2009
Cost-effectiveness analyses of drug eluting stents versus bare metal stents: a systematic review of the literatureMattias Neyt, Hans Van Brabandt, Stephan Devriese, et al.
International Archives of Allergy and Immunology|June 30, 2021
Unraveling the Mystery of Polyvalent Immunoglobulins in Belgium: Do We Have an Indication?Christophe de Meester, Jolyce Bourgeois, Stephan Devriese, et al.
BMC Pulmonary Medicine|September 17, 2010
Tiotropium's cost-effectiveness for the treatment of COPD: a cost-utility analysis under real-world conditionsMattias Neyt, Stephan Devriese, Nancy Thiry, et al.
Consciousness and Cognition|September 1, 2004
Contingency awareness in a symptom learning paradigm: necessary but not sufficient?Stephan Devriese, Winnie Winters, Ilse Van Diest, et al.
BMJ Open|May 8, 2012
A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable populationMattias Neyt, Hans Van Brabandt, Stephan Devriese, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Plos One|April 10, 2018
First- and second-line bevacizumab in ovarian cancer: A Belgian cost-utility analysisMattias Neyt, Joan Vlayen, Stephan Devriese, et al.
Health Policy (Amsterdam, Netherlands)|July 10, 2018
A multi-criteria decision approach for ranking unmet needs in healthcareIrina Cleemput, Stephan Devriese, Laurence Kohn, et al.
Pharmacoeconomics - Open|August 4, 2022
An EQ-5D-5L Value Set for BelgiumNicolas Bouckaert, Irina Cleemput, Stephan Devriese, et al.
Pharmacoeconomics|January 11, 2025
Projections of Public Spending on Pharmaceuticals: A Review of MethodsIrina Odnoletkova, Patrice X Chalon, Stephan Devriese, et al.
Journal of Thrombosis and Thrombolysis|March 23, 2012
Economic evaluation of the use of point-of-care devices in patients with long term oral anticoagulationSophie Gerkens, Jeannine Gailly, Caroline Obyn, et al.
Health Policy (Amsterdam, Netherlands)|January 13, 2009
Cost-effectiveness analyses of drug eluting stents versus bare metal stents: a systematic review of the literatureMattias Neyt, Hans Van Brabandt, Stephan Devriese, et al.
International Archives of Allergy and Immunology|June 30, 2021
Unraveling the Mystery of Polyvalent Immunoglobulins in Belgium: Do We Have an Indication?Christophe de Meester, Jolyce Bourgeois, Stephan Devriese, et al.
BMC Pulmonary Medicine|September 17, 2010
Tiotropium's cost-effectiveness for the treatment of COPD: a cost-utility analysis under real-world conditionsMattias Neyt, Stephan Devriese, Nancy Thiry, et al.
Consciousness and Cognition|September 1, 2004
Contingency awareness in a symptom learning paradigm: necessary but not sufficient?Stephan Devriese, Winnie Winters, Ilse Van Diest, et al.
BMJ Open|May 8, 2012
A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable populationMattias Neyt, Hans Van Brabandt, Stephan Devriese, et al.
Pageof 3